Ontario study suggests. When people who are elderly start taking drugs to control blood pressure , it can potentially cause a dizzy spell when blood pressure falls suddenly when standing. The effect ...

The FDA has approved AstraZeneca's aldosterone synthase inhibitor (ASI) – baxdrostat – for hard-to-treat hypertension, making ...

AstraZeneca’s BAXFENDY™ (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive ...

Deprescribing antihypertensive medications is associated with a 12% lower likelihood of cognitive decline in older nursing home residents, a new study suggests. The association was strongest among ...

Please provide your email address to receive an email when new articles are posted on . Zilebesiran lowered systolic BP for 3 months, a reduction sustained at 6 months. Rates of major adverse events ...

Hypertension—defined as a systolic blood pressure ≥140 mm Hg or a diastolic blood pressure ≥90 mm Hg—is highly prevalent: at least one-quarter of all adults and more than half of those over 60 years ...

LONDON — Two new trials have confirmed that time of day does not matter when it comes to taking antihypertensive medication. Both the BedMed and BedMed-Frail trials, presented at the European Society ...

Since the beginning of the pandemic, everything and its opposite has been said about antihypertensive medications. Used in patients suffering from high blood pressure, these medications were first ...

Two types of drugs that are recommended as a first treatment for patients with high blood pressure were found equally effective in improving cardiovascular outcomes, but the more popular type causes ...